John G. Freund MD - 09 Jun 2025 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role
Director
Signature
/s/ Colleen Tupper as Attorney-in-Fact for John G. Freund, MD
Issuer symbol
COLL
Transactions as of
09 Jun 2025
Net transactions value
-$399
Form type
4
Filing time
11 Jun 2025, 17:04:15 UTC
Previous filing
06 Jun 2025
Next filing
11 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Freund John Gordon Director C/O COLLEGIUM PHARMACEUTICAL, INC., 100 TECHNOLOGY CENTER DRIVE, STOUGHTON /s/ Colleen Tupper as Attorney-in-Fact for John G. Freund, MD 11 Jun 2025 0001296771

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Options Exercise $201,750 +15,000 +24% $13.45 77,259 09 Jun 2025 Direct
transaction COLL Common Stock Sale $202,149 -6,601 -8.5% $30.62 70,658 09 Jun 2025 Direct F1
holding COLL Common Stock 8,625 09 Jun 2025 By: Skyline Venture Management V, LLC F2
holding COLL Common Stock 34,788 09 Jun 2025 By: John Freund Family Partnership IV, L.P. F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COLL Stock Option (Right to Purchase) Options Exercise $0 -15,000 -100% $0.000000 0 09 Jun 2025 Common Stock 15,000 $13.45 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.62 to $30.628, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The shares are held by Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management V, LLC. The reporting person disclaims beneficial ownership of all the shares held by Skyline Venture Management V, LLC except to the extent of his proportionate pecuniary interest therein.
F3 The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The reporting person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The reporting person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein.
F4 The option is fully vested and exercisable.